Übersetzung für "Payor" in Deutsch

Where the recipient and the payor of a dividend are both residents of the Federal Republic of Germany and the dividend is attributed to a permanent establishment or a fixed base that the recipient of the dividend has in the United States, the Federal Republic of Germany may tax such a dividend at the rates provided for in paragraphs 2 and 3 of Article 10 (Dividends).

Where the recipient and the payor of a dividend are both residents of the Federal Republic of Germany and the dividend is attributed to a permanent establishment that the recipient of the dividend has in the United States, the Federal Republic of Germany may tax such a dividend at the rates provided for in paragraphs 2 and 3 of Article 10 (Dividends).

And, commercial and government payors are demanding more effective cost controls.

The increase was partially offset by lower revenue from commercial payors, as expected, and higher implicit price concessions (IFRS 15).

While payment and collection practices vary not only between countries but also between individual authorities, governmental payors usually represent a lower to moderate credit risk.

We envision a product so well designed that it will answer many of the unmet needs of the marketplace and therefore will be able to access valuable user data that the clinical Providers and the Payors desperately need in order to improve clinical services and commercial efficiencies. " said Lahav Gil, CEO, Relay Medical Corp.

Medication non-adherence is a world-wide problem that costs payors and healthcare systems billions of dollars annually and puts consumers at significant risk.

The Company's mandate is to improv e consumer's relationships with their medications and foster a more cohesive ecosystem between patients, doctors, carers, providers, and payors.

Payors want to reduce spending, and pharmacies need a direct conduit to consumers and additional paid services.

In this context, the identification of relevant stakeholders from the target groups of physicians, associations, payors, agencies and service providers is especially important.

Current health care systems are a complex combination of public- and private-sector organizations, providers, payors, pharmaceutical companies and other adjacent players.

The product mission is to improve consumer s ' relationships with their medications and foster a more cohesive ecosystem between patients, doctors, care give rs, providers, and payors.

Medication non-adherence is a global problem that costs payors and healthcare systems billions of dollars annually and puts consumers at significant risk.

The increase was mainly driven by higher utilization of calcimimetics and an increase in the ESRD PPS base rate, partially offset by lower revenue from commercial payors.

Pharmatrac Market Medication non-adherence is a world-wide problem that costs payors and healthcare systems billions of dollars annually and puts consumers at significant risk.

The product mission is to improve consumer's relationships with their medications and foster a more cohesive ecosystem between patients, doctors, carers, providers, and payors.

Payors increasingly no longer reimburse the components of this type of holistic treatment separately but combined in a “service bundle”, which is linked to contractually defined, measurable treatment targets on which the dialysis provider must submit regular reports (pay for performance).

On the other hand, however, it looks as if the pharmaceutical industry will have to grant higher rebates to public payors in future. It has also been proposed that hospital reimbursement rates should be reduced. That could increase pressure on the pharmaceutical industry.